More than 300 scientists will consider the evidence on over 25 virus families and bacteria—as well as “Disease X” (an unknown pathogen that could cause a serious international epidemic)—and recommend a list of priority pathogens that need further research and investment.
Incorporating bioinformatics platforms can ease the burden of tracking, analyzing and managing the use of antibiotics.
During an outbreak, it is critical to treat reusable medical devices as potential sources of transmission.
Treatment can no longer be one dimensional.
Each year, more than 250,000 Americans die from the common and deadly condition.